Active Movers -Generex Biotechnology Corporation (OTCMKTS:GNBT), Catalyst Pharmaceutical Partners, Inc.(NASDAQ:CPRX), RadioShack Corporation(NYSE:RSH), Rigel Pharmaceuticals, Inc.(NASDAQ:RIGL)

Stamford, CT -- (SBWIRE) -- 12/28/2013 -- Jet Life Penny Stocks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Generex Biotechnology Corporation (OTCMKTS:GNBT), Catalyst Pharmaceutical Partners, Inc.(NASDAQ:CPRX), RadioShack Corporation (NYSE:RSH), Rigel Pharmaceuticals, Inc.(NASDAQ:RIGL) Generex Biotechnology Corporation (OTCMKTS:GNBT) was a volume gainer of 1.53 million shares and the average volume of the stock remained 1.82 million shares. The stock opened the session at $0.03 and finished at the end of the day at $0.0290.The market capitalization of the stock remained 16.83 million. Generex Biotechnology Corporation, a development stage company, is engaged in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological diseases. Generex Biotechnology Corporation was founded in 1983 and is based in Toronto, Canada. Is GNBT a Solid Investment at These Levels? Read This Report For Details In the preceding trading session, Catalyst Pharmaceutical Partners, Inc.(NASDAQ:CPRX) exchanged 1.51 million shares and the average volume remained 1.15 million shares. The stock closed the session at $2.10 with the drop of -4.11%. Catalyst Pharmaceutical Partners, Inc. operates as development-stage specialty pharmaceutical company. It focuses on the development and commercialization of novel prescription drugs targeting rare (orphan) neuromuscular and neurological diseases and disorders. Why Should Investors Buy CPRX After the Recent Fall? Just Go Here and Find Out RadioShack Corporation (NYSE:RSH) enhanced 2.30% and its closing price was $2.67. The volume of the stock was 1.48 million shares and the average volume remained 1.71 million shares. The market capitalization of the stock remained 267.43 million. The beta of the stock remained 1.53. RadioShack Corporation engages in the retail sale of consumer electronics goods and services through its RadioShack store chain. The company operates in two segments, U.S. RadioShack company-operated stores and Target Mobile centers. The company also sells its products through Website, radioshack.com. RadioShack Corporation was founded in 1899 and is headquartered in Fort Worth, Texas. Why Should Investors Buy RSH After The Recent Gain? Just Go Here and Find Out Rigel Pharmaceuticals, Inc.(NASDAQ:RIGL) exchanged 1.46 million shares in the previous trading session, and its average trading remained 1.06 million shares. RIGL advanced 3.79% and it closed the trading at $2.74. The market capitalization of the stock remained 239.56 million. Rigel Pharmaceuticals, Inc., a clinical-stage drug development company, discovers and develops novel and small-molecule drugs for the treatment of inflammatory and autoimmune diseases, as well as muscle disorders. The company was founded in 1996 and is based in South San Francisco, California. For How Long RIGL’s Gloss will Attract Investors? Find out via this report